SCHEMBL16596185

SCHEMBL16596185

Cc1cccc2cc(C)n(-c3c(F)cccc3F)c(=O)c12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 8/20 0.45
PDE4A P27815 2/20 0.45
PDE4B Q07343 2/20 0.45
PDE4C Q08493 2/20 0.45
PDE4D Q08499 2/20 0.45
PDE7B Q9NP56 2/20 0.45
MAPK14 Q16539 4/20 0.43
CYP1A2 P05177 1/20 0.41
PIK3R1 P27986 1/20 0.39
PIK3CA P42336 1/20 0.39
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
PIK3CG P48736 1/20 0.36
PIK3CD O00329 1/20 0.36
GRM4 Q14833 1/20 0.35
HTR7 P34969 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18885591 0.85 MAPK14 (0.46) PDE7APDE4APDE4BPDE4CPDE4D
SCHEMBL16591281 0.83 PDE7A (0.42) PDE7APDE4APDE4BPDE4CPDE4D
SCHEMBL16596822 0.82 CYP1A2 (0.41) MAPK14CYP1A2PIK3R1PIK3CAPIK3CG
SCHEMBL18885583 0.80 PDE7A (0.42) PDE7APDE4APDE4BPDE4CPDE4D
SCHEMBL16596148 0.79 NOTUM (0.48) CYP1A2PIK3CD
SCHEMBL16596154 0.78 ALDH1A1 (0.43) CYP1A2PIK3R1PIK3CGPIK3CD
SCHEMBL16596818 0.78 PIK3CD (0.49) CYP1A2PIK3R1PIK3CAPIK3CGPIK3CD
SCHEMBL16596150 0.76 PIK3CD (0.42) PIK3R1PIK3CGPIK3CD
SCHEMBL16596931 0.75 PIK3CD (0.49) PDE7APDE4APDE4BPDE4CPDE4D
SCHEMBL16596147 0.74 NOTUM (0.48) MAPK14PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657007-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2017-05-23 US disclosed
US-9512114-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2016-12-06 US disclosed
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2016-11-03 US disclosed
US-20150087658-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 US disclosed
WO-2015042078-A2 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 PDE7A 525/4885PDE4A 697/4885PDE4B 687/4885
US-20150087658-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 PDE7A 525/4885PDE4A 697/4885PDE4B 687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.